-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Quoin Pharmaceuticals, Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q4 2024.
- Quoin Pharmaceuticals, Ltd. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$2.31M, a 12.8% decline year-over-year.
- Quoin Pharmaceuticals, Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$8.96M, a 3.18% decline year-over-year.
- Quoin Pharmaceuticals, Ltd. annual Net Income (Loss) Attributable to Parent for 2024 was -$8.96M, a 3.18% decline from 2023.
- Quoin Pharmaceuticals, Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.69M, a 7.41% increase from 2022.
- Quoin Pharmaceuticals, Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$9.38M, a 56.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)